VU6007477, a Novel M PAM Based on a Pyrrolo[2,3-]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events
AUTHORS
Engers
JLJulie L ,
Childress
ESElizabeth S ,
Long
MFMadeline F ,
Capstick
RARory A ,
Luscombe
VBVincent B ,
Cho
HPHekyung P ,
Dickerson
JWJonathan W ,
Rook
JMJerri M ,
Blobaum
ALAnna L ,
Niswender
CMColleen M ,
Engers
DWDarren W ,
Conn
PJP Jeffrey ,
Lindsley
CWCraig W .
ACS medicinal chemistry letters. 2018 9 4; 9(9).
917-922
- PMID: 30258541[PubMed].
ABSTRACT
Tags: 2018